Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
national blog main
new york blog main
new york top stories
regeneron pharmaceuticals
3
×
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
arches
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
david schenkein
debate
detroit blog main
detroit top stories
digital
donald trump
drug price
econmoic impact
elimination
fda
food and drug administartion
georgia
glioblastoma
gv
iclaprim
indiana blog main
indiana top stories
international price index
jim greenwood
joao siffert
keytruda
life sciences
lower
What
based
3
×
american
best
bio
continue
crash
debate
healthcare
industry
kind
nash
people
pharmaceutical
policy
politicians
pressure
roundup
scalps
trump’s
u.s
alnylam
cholesterol
data
drug
evidence
heart
lasting
long
looms
lowering
medco
medicines
new
partner
pharmaceuticals
presented
reckoning
rna
supporting
term
Language
Current search:
xconomy.com
×
based
×
" boston blog main "
×
" regeneron pharmaceuticals "
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
